KORU Medical Systems, Inc. (KRMD)
Automate Your Wheel Strategy on KRMD
With Tiblio's Option Bot, you can configure your own wheel strategy including KRMD - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol KRMD
- Rev/Share 0.7977
- Book/Share 0.3578
- PB 11.0129
- Debt/Equity 0.2098
- CurrentRatio 2.9053
- ROIC -0.2328
- MktCap 182165900.0
- FreeCF/Share -0.047
- PFCF -83.8869
- PE -40.3102
- Debt/Assets 0.1359
- DivYield 0
- ROE -0.2679
- Rating D+
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | KRMD | Piper Sandler | Overweight | Neutral | -- | $4.5 | Feb. 14, 2025 |
News
Are You Looking for a Top Momentum Pick? Why KORU Medical Systems, Inc. (KRMD) is a Great Choice
Published: August 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Does KORU Medical Systems, Inc. (KRMD) have what it takes to be a top stock pick for momentum investors? Let's find out.
Read More
Cirtec Medical Announces Appointment of New Chief Executive Officer
Published: August 28, 2025 by: GlobeNewsWire
Sentiment: Neutral
BROOKLYN PARK, Minn., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical, a leading strategic outsourcing partner for complex minimally invasive, active implantable devices and precision components, is pleased to announce the appointment of Shar Matin as Chief Executive Officer, effective September 2, 2025.
Read More
KORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Negative
KORU Medical Systems Inc. (KRMD) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.02 per share a year ago.
Read More
KORU Medical Systems Has A Long Runway
Published: February 10, 2025 by: Seeking Alpha
Sentiment: Positive
KORU Medical Systems' stock has surged 60% since November, driven by the success of its FREEDOM System for subcutaneous immunoglobulin delivery. The SCIg market is growing rapidly, with KORU outperforming competitors by capturing market share and benefiting from trends like prefilled syringes. Strong international growth, new therapies, and product innovations are key drivers, with significant revenue from recurring patients and promising future launches.
Read More
About KORU Medical Systems, Inc. (KRMD)
- IPO Date 1994-04-05
- Website https://www.korumedical.com
- Industry Medical - Instruments & Supplies
- CEO Linda M. Tharby
- Employees 80